Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant Recipients.

Lindemann M, Oesterreich S, Wilde B, Eisenberger U, Muelling N, Horn PA, Heinemann FM, Witzke O.

Vaccines (Basel). 2019 Aug 6;7(3). pii: E84. doi: 10.3390/vaccines7030084.

2.

Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.

Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H.

Transplant Rev (Orlando). 2019 Oct;33(4):191-199. doi: 10.1016/j.trre.2019.07.001. Epub 2019 Jul 23. Review.

PMID:
31377099
3.

Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.

Friebus-Kardash J, Gäckler A, Kribben A, Witzke O, Wedemeyer H, Treckmann J, Herzer K, Eisenberger U.

Transpl Infect Dis. 2019 Oct;21(5):e13146. doi: 10.1111/tid.13146. Epub 2019 Jul 31.

PMID:
31306562
4.

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.

Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, König IR, Kurschat C, Lehmann C, Marget M, Mühlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Süsal C, Thiele B, Zecher D, Lachmann N.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1056-1066. doi: 10.2215/CJN.13401118. Epub 2019 Jun 18.

PMID:
31213508
5.

Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants.

Gäckler A, Dolff S, Rohn H, Korth J, Wilde B, Eisenberger U, Mitchell A, Kribben A, Witzke O.

BMC Nephrol. 2019 May 14;20(1):167. doi: 10.1186/s12882-019-1340-z.

6.

Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.

Friebus-Kardash J, Eisenberger U, Ackermann J, Kribben A, Witzke O, Wenzel J, Rohn H, Fiedler M.

Transpl Infect Dis. 2019 Jun;21(3):e13088. doi: 10.1111/tid.13088. Epub 2019 Apr 16.

PMID:
30929308
7.

[Lupus nephritis].

Schreiber J, Eisenberger U, de Groot K.

Internist (Berl). 2019 May;60(5):468-477. doi: 10.1007/s00108-019-0574-y. Review. German.

PMID:
30840107
8.

Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function.

Eisenberger U, Friebus-Kardash J, Guberina H, Kribben A, Witzke O, Willuweit K, Gerken G, Herzer K.

Transplant Direct. 2018 Dec 27;5(1):e419. doi: 10.1097/TXD.0000000000000860. eCollection 2019 Jan.

9.

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.

Sommerer C, Witzke O, Lehner F, Arns W, Reinke P, Eisenberger U, Vogt B, Heller K, Jacobi J, Guba M, Stahl R, Hauser IA, Kliem V, Wüthrich RP, Mühlfeld A, Suwelack B, Duerr M, Paulus EM, Zeier M, Porstner M, Budde K; ZEUS and HERAKLES study investigators.

BMC Nephrol. 2018 Sep 19;19(1):237. doi: 10.1186/s12882-018-1031-1.

10.

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.

Eisenberger U, Budde K, Lehner F, Sommerer C, Reinke P, Witzke O, Wüthrich RP, Stahl R, Heller K, Suwelack B, Mühlfeld A, Hauser IA, Nadalin S, Porstner M, Arns W; ZEUS Study Investigators.

BMC Nephrol. 2018 Jun 28;19(1):154. doi: 10.1186/s12882-018-0950-1.

11.

Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2018 Apr 12;8(1):6003. doi: 10.1038/s41598-018-23760-1.

12.

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.

Dahdal S, Devetzis V, Chalikias G, Tziakas D, Chizzolini C, Ribi C, Trendelenburg M, Eisenberger U, Hauser T, Pasch A, Huynh-Do U, Arampatzis S; Swiss Systemic Lupus Erythematosus Cohort Study Group.

PLoS One. 2018 Jan 24;13(1):e0188695. doi: 10.1371/journal.pone.0188695. eCollection 2018.

13.

Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.

Friebus-Kardash J, Wilde B, Keles D, Heinold A, Kribben A, Witzke O, Heinemann FM, Eisenberger U.

Transpl Immunol. 2018 Apr;47:10-17. doi: 10.1016/j.trim.2017.12.004. Epub 2017 Dec 23.

PMID:
29277566
14.

Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2017 Nov 6;7(1):14554. doi: 10.1038/s41598-017-14674-5. Erratum in: Sci Rep. 2018 Apr 12;8(1):6003.

15.

Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.

Friebus-Kardash J, Branco L, Ribi C, Chizzolini C, Huynh-Do U, Dubler D, Roux-Lombard P, Dolff S, Kribben A, Eisenberger U, Trendelenburg M.

Nephrol Dial Transplant. 2018 Jan 1;33(1):54-64. doi: 10.1093/ndt/gfx220.

PMID:
28992184
16.

Transplanting HCV-Infected Kidneys into Uninfected Recipients.

Halleck F, Budde K, Duerr M, Staeck O, Hofmann J, Eisenberger U, Herzer K, Sterneck M, Gottlieb J, Schulz U.

N Engl J Med. 2017 Sep 14;377(11):1103-4. doi: 10.1056/NEJMc1709315. No abstract available.

PMID:
28902583
17.

Rescue allocation and recipient oriented extended allocation in kidney transplantation-influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially nonaccepted organs.

Wahba R, Suwelack B, Arns W, Cakiroglu F, Eisenberger U, Feldkamp T, Hansen A, Ivens K, Klein T, Kribben A, Kurschat C, Lange U, Mühlfeld A, Nitschke M, Reuter S, Schulte K, Viebahn R, Woitas R, Hellmich M, Stippel DL.

Transpl Int. 2017 Dec;30(12):1226-1233. doi: 10.1111/tri.12993. Epub 2017 Jul 31.

18.

Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.

Ziemann M, Heßler N, König IR, Lachmann N, Dick A, Ditt V, Budde K, Reinke P, Eisenberger U, Suwelack B, Klein T, Westhoff TH, Arns W, Ivens K, Habicht A, Renders L, Stippel D, Bös D, Sommer F, Görg S, Nitschke M, Feldkamp T, Heinemann FM, Kelsch R.

Nephrol Dial Transplant. 2017 May 1;32(5):880-889. doi: 10.1093/ndt/gfw462.

PMID:
28340245
19.

Effect of ABO incompatibility on T-cell flow cytometry cross-match results prior to living donor kidney transplantation.

Lindemann M, Lenz V, Nyadu B, Heinemann FM, Heinold A, Guberina H, Eisenberger U, Lachmann N, Schönemann C, Kribben A, Paul A, Horn PA, Witzke O.

Cytometry B Clin Cytom. 2018 Jul;94(4):623-630. doi: 10.1002/cyto.b.21496. Epub 2016 Dec 7.

20.

Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients.

Eisenberger U, Guberina H, Willuweit K, Bienholz A, Kribben A, Gerken G, Witzke O, Herzer K.

Transplantation. 2017 May;101(5):980-986. doi: 10.1097/TP.0000000000001414. Erratum in: Transplantation. 2018 Oct;102(10):e458.

PMID:
27495770
21.

Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial.

Sommerer C, Budde K, Zeier M, Wüthrich RP, Reinke P, Eisenberger U, Mühlfeld A, Arns W, Stahl R, Heller K, Wolters HH, Suwelack B, Klehr HU, Hauser IA, Stangl M, Nadalin S, Dürr M, Porstner M, May C, Wimmer P, Witzke O, Lehner F.

Clin Nephrol. 2016 Apr;85(4):215-25. doi: 10.5414/CN108726.

PMID:
26932178
22.

Renal Blood Oxygenation Level-dependent Imaging in Longitudinal Follow-up of Donated and Remaining Kidneys.

Seif M, Eisenberger U, Binser T, Thoeny HC, Krauer F, Rusch A, Boesch C, Vogt B, Vermathen P.

Radiology. 2016 Jun;279(3):795-804. doi: 10.1148/radiol.2015150370. Epub 2016 Jan 8.

PMID:
26744926
23.

Calcification Propensity and Survival among Renal Transplant Recipients.

Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, Bergmann IP, Floege J, Navis G, Bakker SJ, van Goor H, Eisenberger U, Pasch A.

J Am Soc Nephrol. 2016 Jan;27(1):239-48. doi: 10.1681/ASN.2014070670. Epub 2015 Apr 29.

24.

Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study.

Budde K, Lehner F, Sommerer C, Reinke P, Arns W, Eisenberger U, Wüthrich RP, Mühlfeld A, Heller K, Porstner M, Veit J, Paulus EM, Witzke O; ZEUS Study Investigators.

Am J Transplant. 2015 Jan;15(1):119-28. doi: 10.1111/ajt.12952. Epub 2014 Dec 17.

25.

The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience.

Schiesser M, Steinemann DC, Hadaya K, Huynh-Do U, Eisenberger U, Binet I, Fehr T, Dickenmann M.

Transplantation. 2015 May;99(5):1030-5. doi: 10.1097/TP.0000000000000457.

26.

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.

Ribi C, Trendelenburg M, Gayet-Ageron A, Cohen C, Dayer E, Eisenberger U, Hauser T, Hunziker T, Leimgruber A, Lindner G, Koenig K, Otto P, Spertini F, Stoll T, Von Kempis J, Chizzolini C; Swiss Systemic Lupus Erythematosus Cohort Study Group.

Swiss Med Wkly. 2014 Aug 7;144:w13990. doi: 10.4414/smw.2014.13990. eCollection 2014.

27.

Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study.

Lehner F, Budde K, Zeier M, Wüthrich RP, Reinke P, Eisenberger U, Mühlfeld A, Arns W, Stahl R, Heller K, Witzke O, Wolters HH, Suwelack B, Klehr HU, Stangl M, Hauser IA, Nadalin S, Porstner M, May C, Paulus EM, Sommerer C; ZEUS Study Investigators.

Transpl Int. 2014 Nov;27(11):1192-204. doi: 10.1111/tri.12411. Epub 2014 Aug 20.

28.

Living renal allograft transplantation: diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidney.

Eisenberger U, Binser T, Thoeny HC, Boesch C, Frey FJ, Vermathen P.

Radiology. 2014 Mar;270(3):800-8. doi: 10.1148/radiol.13122588. Epub 2013 Nov 13.

PMID:
24475796
29.

Reference values and factors associated with renal resistive index in a family-based population study.

Ponte B, Pruijm M, Ackermann D, Vuistiner P, Eisenberger U, Guessous I, Rousson V, Mohaupt MG, Alwan H, Ehret G, Pechere-Bertschi A, Paccaud F, Staessen JA, Vogt B, Burnier M, Martin PY, Bochud M.

Hypertension. 2014 Jan;63(1):136-42. doi: 10.1161/HYPERTENSIONAHA.113.02321. Epub 2013 Oct 14.

PMID:
24126174
30.

Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants.

Eisenberger U, Wüthrich RP, Bock A, Ambühl P, Steiger J, Intondi A, Kuranoff S, Maier T, Green D, DiCarlo L, Feutren G, De Geest S.

Transplantation. 2013 Aug 15;96(3):245-50. doi: 10.1097/TP.0b013e31829b7571.

31.

Heritability, determinants and reference values of renal length: a family-based population study.

Pruijm M, Ponte B, Ackermann D, Vuistiner P, Paccaud F, Guessous I, Ehret G, Eisenberger U, Mohaupt M, Burnier M, Martin PY, Bochud M.

Eur Radiol. 2013 Oct;23(10):2899-905. doi: 10.1007/s00330-013-2900-4. Epub 2013 May 28.

PMID:
23712436
32.

Arterial stiffness depends on serum ionized calcium levels during dialysis with regional citrate anticoagulation.

Moor MB, Kruse A, Uehlinger DE, Eisenberger U.

Artif Organs. 2013 May;37(5):467-74. doi: 10.1111/aor.12037. Epub 2013 Mar 15.

PMID:
23495916
33.

Serum cytokine profile in patients with active lupus nephritis.

Koenig KF, Groeschl I, Pesickova SS, Tesar V, Eisenberger U, Trendelenburg M.

Cytokine. 2012 Nov;60(2):410-6. doi: 10.1016/j.cyto.2012.07.004. Epub 2012 Jul 28.

PMID:
22846145
34.

Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.

Budde K, Lehner F, Sommerer C, Arns W, Reinke P, Eisenberger U, Wüthrich RP, Scheidl S, May C, Paulus EM, Mühlfeld A, Wolters HH, Pressmar K, Stahl R, Witzke O; ZEUS Study Investigators.

Am J Transplant. 2012 Jun;12(6):1528-40. doi: 10.1111/j.1600-6143.2012.03994.x. Epub 2012 Mar 5. Erratum in: Am J Transplant. 2012 Nov;12(11):3165.

35.

Three-year follow-up of human transplanted kidneys by diffusion-weighted MRI and blood oxygenation level-dependent imaging.

Vermathen P, Binser T, Boesch C, Eisenberger U, Thoeny HC.

J Magn Reson Imaging. 2012 May;35(5):1133-8. doi: 10.1002/jmri.23537. Epub 2011 Dec 16.

PMID:
22180302
36.

[Renal transplantation - new developments].

Eisenberger U.

Ther Umsch. 2011 Dec;68(12):687-92. doi: 10.1024/0040-5930/a000231. Review. German.

PMID:
22139983
37.

Donor effect on cortical perfusion intensity in renal allograft recipients: a paired kidney analysis.

Marti E, Bergmann IP, Uehlinger DE, Frey FJ, Eisenberger U.

Am J Nephrol. 2011;33(6):530-6. doi: 10.1159/000328383. Epub 2011 May 23.

PMID:
21606644
38.

Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization.

Willenberg T, Baumann F, Eisenberger U, Baumgartner I, Do DD, Diehm N.

J Vasc Surg. 2011 Jun;53(6):1589-97. doi: 10.1016/j.jvs.2011.01.062. Epub 2011 Apr 30.

39.

[New radiological techniques to investigate patients suffering from chronic kidney disease].

Pruijm M, Ponte B, Hofmann L, Vogt B, Eisenberger U, Meuwly JY, Burnier M.

Rev Med Suisse. 2011 Mar 2;7(284):505-9. French.

PMID:
21462521
40.

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

Budde K, Becker T, Arns W, Sommerer C, Reinke P, Eisenberger U, Kramer S, Fischer W, Gschaidmeier H, Pietruck F; ZEUS Study Investigators.

Lancet. 2011 Mar 5;377(9768):837-47. doi: 10.1016/S0140-6736(10)62318-5. Epub 2011 Feb 19. Erratum in: Lancet. 2011 Jun 11;377(9782):2006. Wüthrich, Rudolf P [added]. Lancet. 2012 Dec 8;380(9858):1994.

PMID:
21334736
41.

Comparison of physiological triggering schemes for diffusion-weighted magnetic resonance imaging in kidneys.

Binser T, Thoeny HC, Eisenberger U, Stemmer A, Boesch C, Vermathen P.

J Magn Reson Imaging. 2010 May;31(5):1144-50. doi: 10.1002/jmri.22156.

PMID:
20432350
42.

Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging.

Eisenberger U, Thoeny HC, Binser T, Gugger M, Frey FJ, Boesch C, Vermathen P.

Eur Radiol. 2010 Jun;20(6):1374-83. doi: 10.1007/s00330-009-1679-9. Epub 2009 Dec 16.

43.

Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients.

Rödder S, Scherer A, Körner M, Eisenberger U, Hertig A, Raulf F, Rondeau E, Marti HP.

Am J Transplant. 2010 Feb;10(2):286-97. doi: 10.1111/j.1600-6143.2009.02928.x. Epub 2009 Dec 2.

44.

Renal resistance index in renal allograft recipients: a role for ADMA.

Bergmann IP, Böger RH, Marti E, Frey FJ, Schwedhelm E, Eisenberger U.

Am J Kidney Dis. 2009 Aug;54(2):327-33. doi: 10.1053/j.ajkd.2009.04.028. Epub 2009 Jun 28.

PMID:
19560848
45.

Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor.

Eisenberger U, Sollinger D, Stickel F, Burckhardt B, Frey FJ.

Clin Transplant. 2009 Aug-Sep;23(4):499-504. doi: 10.1111/j.1399-0012.2009.00986.x. Epub 2009 Apr 17.

PMID:
19486346
46.

[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)].

Chizzolini C, Cohen CD, Eisenberger U, Hauser T, Hunziker T, Leimgruber A, Pechula M, Ribi C, Stoll T, Trendelenburg M; Groupe de travail de la SSCS.

Rev Med Suisse. 2009 Apr 15;5(199):808-11. French.

47.

FoxP3 positive T cells in graft biopsies from living donor kidney transplants after donor-specific transfusions.

Eisenberger U, Seifried A, Patey N, Kappeler A, Noel LH, Frey FJ, Körner M.

Transplantation. 2009 Jan 15;87(1):138-42. doi: 10.1097/TP.0b013e3181900278.

PMID:
19136904
48.

[Systemic ANCA-associated vasculitis--diagnosis and therapy].

Eisenberger U, Hess C.

Ther Umsch. 2008 May;65(5):295-301. doi: 10.1024/0040-5930.65.5.295. Review. German.

PMID:
18622935
49.

PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.

Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O.

Nephrol Dial Transplant. 2008 Aug;23(8):2563-70. doi: 10.1093/ndt/gfn091. Epub 2008 Apr 8.

50.

Pulse contour analysis: a valid assessment of central arterial stiffness in children?

Simonetti GD, Eisenberger U, Bergmann IP, Frey FJ, Mohaupt MG.

Pediatr Nephrol. 2008 Mar;23(3):439-44. Epub 2007 Dec 21.

Supplemental Content

Loading ...
Support Center